{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T22:08:00Z","timestamp":1750284480558,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s00520-024-08716-8","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T11:02:10Z","timestamp":1720609330000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The safety and effectiveness of naldemedine for opioid-induced constipation in patients with advanced cancer in real-world palliative care settings: a multicenter prospective observational study"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9441-3890","authenticated-orcid":false,"given":"Masaki","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0018-3359","authenticated-orcid":false,"given":"Isseki","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaomi","family":"Kessoku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0800-2161","authenticated-orcid":false,"given":"Hiroto","family":"Ishiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2334-3893","authenticated-orcid":false,"given":"Yusuke","family":"Hiratsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5092-9377","authenticated-orcid":false,"given":"Yoshinobu","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7894-4528","authenticated-orcid":false,"given":"Takaaki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kengo","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8130-6815","authenticated-orcid":false,"given":"Shunsuke","family":"Oyamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1516-2849","authenticated-orcid":false,"given":"Eriko","family":"Satomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"On behalf of the Phase-R OIC Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,10]]},"reference":[{"key":"8716_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1526-4637.2008.00495.x","volume":"10","author":"TJ Bell","year":"2009","unstructured":"Bell TJ, Panchal SJ, Miaskowski C et al (2009) The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1). Pain Med 10:35\u201342. https:\/\/doi.org\/10.1111\/j.1526-4637.2008.00495.x","journal-title":"Pain Med"},{"key":"8716_CR2","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/ajg.2011.30","volume":"106","author":"M Camilleri","year":"2011","unstructured":"Camilleri M (2011) Opioid-induced constipation: challenges and therapeutic opportunities. Am J Gastroenterol 106:835\u201342. https:\/\/doi.org\/10.1038\/ajg.2011.30. (quiz 843)","journal-title":"Am J Gastroenterol"},{"key":"8716_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11864-019-0686-6","volume":"20","author":"R Mes\u00eda","year":"2019","unstructured":"Mes\u00eda R, VirizuelaEchaburu JA, G\u00f3mez J et al (2019) Opioid-induced constipation in oncological patients: new strategies of management. Curr Treat Options Oncol 20:91. https:\/\/doi.org\/10.1007\/s11864-019-0686-6","journal-title":"Curr Treat Options Oncol"},{"key":"8716_CR4","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1053\/j.gastro.2018.07.016","volume":"156","author":"SD Crockett","year":"2019","unstructured":"Crockett SD, Greer KB, Heidelbaugh JJ et al (2019) American gastroenterological association institute guideline on the medical management of opioid-induced constipation. Gastroenterology 156:218\u2013226. https:\/\/doi.org\/10.1053\/j.gastro.2018.07.016","journal-title":"Gastroenterology"},{"key":"8716_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1053\/j.gastro.2018.08.018","volume":"156","author":"B Hanson","year":"2019","unstructured":"Hanson B, Siddique SM, Scarlett Y, Sultan S (2019) American gastroenterological association institute technical review on the medical management of opioid-induced constipation. Gastroenterology 156:229-253.e5. https:\/\/doi.org\/10.1053\/j.gastro.2018.08.018","journal-title":"Gastroenterology"},{"key":"8716_CR6","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.2147\/jpr.S243435","volume":"13","author":"F Coluzzi","year":"2020","unstructured":"Coluzzi F, Scerpa MS, Pergolizzi J (2020) Naldemedine: a new option for OIBD. J Pain Res 13:1209\u20131222. https:\/\/doi.org\/10.2147\/jpr.S243435","journal-title":"J Pain Res"},{"key":"8716_CR7","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/s2468-1253(17)30105-x","volume":"2","author":"M Hale","year":"2017","unstructured":"Hale M, Wild J, Reddy J et al (2017) Naldemedine versus placebo for opioid-induced constipation (COMPOSE-1 and COMPOSE-2): two multicentre, phase 3, double-blind, randomised, parallel-group trials. Lancet Gastroenterol Hepatol 2:555\u2013564. https:\/\/doi.org\/10.1016\/s2468-1253(17)30105-x","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"8716_CR8","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1097\/j.pain.0000000000001174","volume":"159","author":"LR Webster","year":"2018","unstructured":"Webster LR, Nalamachu S, Morlion B et al (2018) Long-term use of naldemedine in the treatment of opioid-induced constipation in patients with chronic noncancer pain: a randomized, double-blind, placebo-controlled phase 3 study. Pain 159:987\u2013994. https:\/\/doi.org\/10.1097\/j.pain.0000000000001174","journal-title":"Pain"},{"key":"8716_CR9","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1200\/jco.2017.73.0853","volume":"35","author":"N Katakami","year":"2017","unstructured":"Katakami N, Harada T, Murata T et al (2017) Randomized phase III and extension studies of naldemedine in patients with opioid-induced constipation and cancer. J Clin Oncol 35:3859\u20133866. https:\/\/doi.org\/10.1200\/jco.2017.73.0853","journal-title":"J Clin Oncol"},{"key":"8716_CR10","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1136\/gutjnl-2018-316001","volume":"68","author":"P Luthra","year":"2019","unstructured":"Luthra P, Burr NE, Brenner DM, Ford AC (2019) Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and network meta-analysis. Gut 68:434\u2013444. https:\/\/doi.org\/10.1136\/gutjnl-2018-316001","journal-title":"Gut"},{"key":"8716_CR11","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1093\/pm\/pnaa152","volume":"21","author":"R Ouyang","year":"2020","unstructured":"Ouyang R, Li Z, Huang S et al (2020) Efficacy and safety of peripherally acting mu-opioid receptor antagonists for the treatment of opioid-induced constipation: a Bayesian network meta-analysis. Pain Med 21:3224\u20133232. https:\/\/doi.org\/10.1093\/pm\/pnaa152","journal-title":"Pain Med"},{"key":"8716_CR12","doi-asserted-by":"publisher","first-page":"Cd006332","DOI":"10.1002\/14651858.CD006332.pub3","volume":"6","author":"B Candy","year":"2018","unstructured":"Candy B, Jones L, Vickerstaff V et al (2018) Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care. Cochrane Database Syst Rev 6:Cd006332. https:\/\/doi.org\/10.1002\/14651858.CD006332.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"8716_CR13","doi-asserted-by":"publisher","unstructured":"Nishiba H, Imai H, Fujita Y et al (2022) Efficacy and safety of naldemedine for patients with cancer with opioid-induced constipation in clinical practice: a real-world retrospective study. J Clin Med 11. https:\/\/doi.org\/10.3390\/jcm11092672","DOI":"10.3390\/jcm11092672"},{"key":"8716_CR14","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1007\/s00520-022-06807-y","volume":"30","author":"K Takata","year":"2022","unstructured":"Takata K, Nakazawa M, Honda K, Hashimoto S (2022) Post-marketing surveillance of the safety and effectiveness of naldemedine in the management of opioid-induced constipation in patients with cancer pain in Japan. Support Care Cancer 30:3943\u20133954. https:\/\/doi.org\/10.1007\/s00520-022-06807-y","journal-title":"Support Care Cancer"},{"key":"8716_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12876-020-1173-z","volume":"20","author":"Y Takagi","year":"2020","unstructured":"Takagi Y, Osawa G, Kato Y et al (2020) Prevention and management of diarrhea associated with naldemedine among patients receiving opioids: a retrospective cohort study. BMC Gastroenterol 20:25. https:\/\/doi.org\/10.1186\/s12876-020-1173-z","journal-title":"BMC Gastroenterol"},{"key":"8716_CR16","unstructured":"Ministry of Education, Culture, Sports, Science and Technology, Ministry of Health, Labour and Welfare (2015) Ethical guidelines for medical research and health research involving human subjects. https:\/\/www.mhlw.go.jp\/file\/06-Seisakujouhou-10600000-Daijinkanboukouseikagakuka\/0000080278.pdf Accessed 10 July 2024"},{"key":"8716_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-27233-2","volume-title":"Nutritional management of cancer treatment effects","author":"NB Kumar","year":"2012","unstructured":"Kumar NB (2012) Nutritional management of cancer treatment effects. Springer, Berlin"},{"key":"8716_CR18","doi-asserted-by":"publisher","first-page":"977","DOI":"10.6004\/jnccn.2019.0038","volume":"17","author":"RA Swarm","year":"2019","unstructured":"Swarm RA, Paice JA, Anghelescu DL et al (2019) Adult cancer pain, version 3.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 17:977\u20131007. https:\/\/doi.org\/10.6004\/jnccn.2019.0038","journal-title":"J Natl Compr Canc Netw"},{"key":"8716_CR19","unstructured":"Japan Clinical Oncology Group (2016) JCOG clinical safety data management guideline (ver.3.1). https:\/\/jcog.jp\/A_020_0010_16_1.pdf Accessed\u00a010 July 2024"},{"key":"8716_CR20","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1097\/j.pain.0000000000001629","volume":"160","author":"J Wild","year":"2019","unstructured":"Wild J, Yamada T, Arjona Ferreira JC, Hale M (2019) Onset of action of naldemedine in the treatment of opioid-induced constipation in patients with chronic noncancer pain: results from 2 randomized, placebo-controlled, phase 3 trials. Pain 160:2358\u20132364. https:\/\/doi.org\/10.1097\/j.pain.0000000000001629","journal-title":"Pain"},{"key":"8716_CR21","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/annonc\/mdy118","volume":"29","author":"N Katakami","year":"2018","unstructured":"Katakami N, Harada T, Murata T et al (2018) Randomized phase III and extension studies: efficacy and impacts on quality of life of naldemedine in subjects with opioid-induced constipation and cancer. Ann Oncol 29:1461\u20131467. https:\/\/doi.org\/10.1093\/annonc\/mdy118","journal-title":"Ann Oncol"},{"key":"8716_CR22","doi-asserted-by":"publisher","first-page":"204209862093859","DOI":"10.1177\/2042098620938595","volume":"11","author":"M Alomar","year":"2020","unstructured":"Alomar M, Tawfiq AM, Hassan N, Palaian S (2020) Post marketing surveillance of suspected adverse drug reactions through spontaneous reporting: current status, challenges and the future. Ther Adv Drug Saf 11:2042098620938595. https:\/\/doi.org\/10.1177\/2042098620938595","journal-title":"Ther Adv Drug Saf"},{"key":"8716_CR23","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1046\/j.1365-2125.1997.05417.x","volume":"43","author":"Y Moride","year":"1997","unstructured":"Moride Y, Haramburu F, Requejo AA, B\u00e9gaud B (1997) Under-reporting of adverse drug reactions in general practice. Br J Clin Pharmacol 43:177\u2013181. https:\/\/doi.org\/10.1046\/j.1365-2125.1997.05417.x","journal-title":"Br J Clin Pharmacol"},{"key":"8716_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.5056\/jnm16214","volume":"23","author":"MJ Schmulson","year":"2017","unstructured":"Schmulson MJ, Drossman DA (2017) What is new in Rome IV. J Neurogastroenterol Motil 23:151\u2013163. https:\/\/doi.org\/10.5056\/jnm16214","journal-title":"J Neurogastroenterol Motil"},{"key":"8716_CR25","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/j.pain.0000000000002024","volume":"162","author":"A Davies","year":"2021","unstructured":"Davies A, Leach C, Butler C et al (2021) Opioid-induced constipation in patients with cancer: a \u201creal-world\u201d, multicentre, observational study of diagnostic criteria and clinical features. Pain 162:309\u2013318. https:\/\/doi.org\/10.1097\/j.pain.0000000000002024","journal-title":"Pain"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08716-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-024-08716-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08716-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T05:05:16Z","timestamp":1723611916000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-024-08716-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,10]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["8716"],"URL":"https:\/\/doi.org\/10.1007\/s00520-024-08716-8","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2024,7,10]]},"assertion":[{"value":"21 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patients were informed about the study concept and how their medical information would be handled. Verbal consent was obtained before enrollment in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All study participants consented to participate after being informed that the medical information collected in this study would not be disclosed in a manner that could identify the individuals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"504"}}